Literature DB >> 34309716

[Retinal tumors in adults - Part 1: vascular tumors of the retina].

Roya Piria1, Felix Rommel2, Michael Zimbelmann2, Kristina Erikson2, Neele Babst2, Anton Brosig2, Josephine Christin Freitag2, Mahdy Ranjbar2, Salvatore Grisanti2, Vinodh Kakkassery2.   

Abstract

Retinal tumors are a heterogeneous group of congenital and acquired lesions. In this review series the important retinal tumors are discussed and presented in two articles. In the first part of the article the most important vascular tumors of the retina are presented. Even with benign tumors visual symptoms, such as exudative retinal detachment occur, which often lead to irreversible visual impairments. Because visual symptoms are often a manifestation of systemic diseases, the ophthalmologist plays an important role in the accurate and early diagnosis of retinal tumors. This article reviews the most important clinical and diagnostic features of retinal vascular tumors in adults, their systemic associations and the literature on currently available treatment strategies.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Cavernous hemangioma; Hemangioma; Retinal tumors; Vascular tumors; Wyborn-Mason syndrome

Year:  2021        PMID: 34309716     DOI: 10.1007/s00347-021-01445-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.

Authors:  Emily Ying Chew
Journal:  Trans Am Ophthalmol Soc       Date:  2005

2.  Hemangioblastomas of the retina: impact of von Hippel-Lindau disease.

Authors:  M Niemelä; S Lemeta; M Sainio; S Rauma; E Pukkala; J Kere; T Böhling; L Laatikainen; J Jääskeläinen; P Summanen
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

3.  Vasoproliferative tumours of the retina.

Authors:  H Heimann; N Bornfeld; O Vij; S E Coupland; N E Bechrakis; U Kellner; M H Foerster
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

4.  Vitreoretinal surgery for severe retinal capillary hemangiomas in von hippel-lindau disease.

Authors:  Alain Gaudric; Valérie Krivosic; Graham Duguid; Pascale Massin; Sophie Giraud; Stéphane Richard
Journal:  Ophthalmology       Date:  2011-01       Impact factor: 12.079

5.  Central Serous Chorioretinopathy in a Case of Regressed Familial Retinoblastoma.

Authors:  Saeed Karimi; Amir Arabi; Toktam Shahraki; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2020-10-25

6.  Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastoma.

Authors:  R N Hussain; F Jmor; B Damato; H Heimann
Journal:  Photodiagnosis Photodyn Ther       Date:  2015-10-20       Impact factor: 3.631

7.  Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma.

Authors:  K M Kreusel; N Bornfeld; A Lommatzsch; A Wessing; M H Foerster
Journal:  Ophthalmology       Date:  1998-08       Impact factor: 12.079

8.  Vascular tumors of the retina and choroid: diagnosis and treatment.

Authors:  Mary E Turell; Arun D Singh
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

9.  Benefits and complications of photodynamic therapy of papillary capillary hemangiomas.

Authors:  Ursula M Schmidt-Erfurth; Christine Kusserow; Irene A Barbazetto; Horst Laqua
Journal:  Ophthalmology       Date:  2002-07       Impact factor: 12.079

Review 10.  Vascular tumors of the choroid and retina.

Authors:  P Mahesh Shanmugam; Rajesh Ramanjulu
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

View more
  1 in total

Review 1.  [Retinal tumors in adults: Part 2 nonvascular tumors of retina and retinal pigment epithelium].

Authors:  Roya Piria; Felix Rommel; Michael Zimbelmann; Kristina Erikson; Neele Babst; Anton Brosig; Josephine Christin Freitag; Mahdy Ranjbar; Salvatore Grisanti; Vinodh Kakkassery
Journal:  Ophthalmologe       Date:  2021-07-29       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.